Sulforaphane (SFN), known for its antioxidant effects, is structurally unstable and easily degrades under the acidic conditions of the gastrointestinal tract. Promising delivery strategies must be developed to stabilize and protect lipophilic compound...
Sulforaphane (SFN), known for its antioxidant effects, is structurally unstable and easily degrades under the acidic conditions of the gastrointestinal tract. Promising delivery strategies must be developed to stabilize and protect lipophilic compounds such as SFN in acidic gastric environments. The objective of this study was to develop an SFN-loaded O/W emulsion coated through complex coacervation (SFN-ECC) to enhance stability and targeted intestinal delivery. The O/W emulsion was prepared by dissolving Tween 80 and ι-carrageenan in water for the aqueous phase and dissolving SFN in sunflower oil for the oil phase. Mung bean protein isolate (MPI) was subsequently mixed to form SFN-ECC. Response surface methodology was used in a two-stage process to optimize SFN-ECC. The initial stage optimized the key emulsion characteristics (stability, droplet size, and distribution), and the subsequent stage focused on encapsulation efficiency, particle size, and coacervate yield. This optimization yielded the following optimal parameters: 54% sunflower oil, 0.60% ι-carrageenan, 8,793 rpm homogenization speed, pH 3.71, and 1.17% MPI. The optimized SFN-ECC possessed a compact core–shell structure driven by strong protein–polysaccharide interactions, resulting in significantly enhanced thermal stability. SFN-ECC exhibited a significantly lower release rate during the simulated gastric phase. In conclusion, SFN-ECC created a structural barrier that efficiently protected SFN from degradation at acidic pH and gastrointestinal digestion while ensuring controlled intestinal delivery. This technology enables improving the bioavailability of unstable bioactive compounds, such as SFN, particularly for use in functional food formulations.